Marco Traub | Chief Executive Officer
TESCT - The Trans European Stem Cell Therapy Society

Dr. Marco Traub has gained considerable experience in several research, management, and educational projects over the past 25 years. He is the founder of the Trans European Stem Cell Therapy Consortium (TESCT) and acts since 2005 as Chair of the TESCT consortium and as EU-Commission Expert (EX2013D138520) in FP7 and the Innovative Medicine Initiative (IMI 1+2) 2018, which is a public private partnership between the European Commission (FP6/FP7/Horizon 2020, Health and Life Sciences) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) and COST framework for Switzerland.